New trial arm to evaluate safety, dosing and preliminary anti-tumor activity of the combination therapy in advanced solid tumorsNEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc.

Abstract: This article introduces two general ways to derive single-phase bridgeless power factor correction (PFC) topologies and then, 15 accessible bridgeless topologies are derived based on the ...